HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G T Elliott Selected Research

RC 552

7/2000The novel glycolipid RC-552 attenuates myocardial stunning and reduces infarct size in dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G T Elliott Research Topics

Disease

3Ischemia
11/2000 - 07/2000
3Infarction (Infarctions)
11/2000 - 07/2000
1Coronary Occlusion
09/2000
1Myocardial Infarction
07/2000
1Myocardial Ischemia (Ischemic Heart Diseases)
07/2000
1Myocardial Stunning (Stunned Myocardium)
07/2000
1Fever (Fevers)
07/2000
1Thrombosis (Thrombus)
03/2000
1Hypotension (Low Blood Pressure)
03/2000

Drug/Important Bio-Agent (IBA)

3monophosphoryl lipid AIBA
09/2000 - 03/2000
2pimagedine (aminoguanidine)IBA
09/2000 - 07/2000
1GenisteinIBA
11/2000
1salicylhydroxamic acid (SHAM)IBA
11/2000
1CreatinineIBA
09/2000
1Pharmaceutical PreparationsIBA
09/2000
1Phosphotransferases (Kinase)IBA
09/2000
1Messenger RNA (mRNA)IBA
09/2000
1GlycolipidsIBA
07/2000
1RC 552IBA
07/2000
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2000
1PyrogensIBA
07/2000
1triphenyltetrazoliumIBA
07/2000
1Interleukin-6 (Interleukin 6)IBA
07/2000
1CytokinesIBA
07/2000
1Interleukin-8 (Interleukin 8)IBA
07/2000
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2000

Therapy/Procedure

1Therapeutics
03/2000